Sunday, 11 March 2018 17:28

(2017.12) Gentren created with IP transfer Featured

Written by
Rate this item
(5 votes)


A collaborative commercialization research institute, named GENTREN (GENoss + itREN) established with the supportive fund (500M/y up to 2 years) from NRF. 

Gentren started to develop and commercialize dental synthetic bone graft materials and other root canal filling materials


Our research and technologies initiated to become reality to the market throughout this project.


This was motivated by the transfer of two intellectural properties of Prof. Kim HW to biomaterials company (Genoss) with 100M won and 3% royalty




Read 1955 times Last modified on Friday, 16 March 2018 04:15
Login to post comments

Recent News